跳至主要内容
临床试验/NCT05174351
NCT05174351招募中不适用

Effect of Beta-blocker Discontinuation on Functional Capacity and Cardiac Hemodynamics in Patients With Heart Failure With Preserved Ejection Fraction

UConn Health2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
2
主要终点
Changes in KCCQ-23 score

研究概览

简要总结

This is a prospective pilot study to evaluate changes before and 4 weeks after beta-blocker withdrawal in 30 HFpEF patients.

详细描述

This is a prospective pilot study to evaluate changes before and 4 weeks(+/- 1 week) after beta-blocker withdrawal in 30 HFpEF patients. The study involves 2 visits that are 4 weeks apart. The first study visit will occur at a standard of care clinic visit and the second visit will be a research visit to fill out questionnaires and perform the limited echocardiogram. No long term follow up beyond the 2nd visit.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stable HFpEF patients with NYHA Class II-III or elevated BNP ≥100
  • N=30 (Target: 30).
  • Age: 50 ~ 80 years.
  • ECHO evidence of EF ≥50% and Grade 2 or 3 diastolic dysfunction.
  • Chronic loop diuretic use
  • Currently on beta-blocker

排除标准

  • Beta blocker was prescribed for treating other cardiac conditions such as atrial fibrillation or coronary artery disease.
  • Heart rate > 100 bpm
  • Recent hospitalization due to HF within 3 months
  • Non-English speaker

结局指标

主要结局

Changes in KCCQ-23 score

时间窗: Baseline and after 4 weeks of beta blocker discontinuation

Kansa city cardiomyopathy questionnaire (KCCQ-23)- self-administered, 23-item. questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life. Scores are transformed to a range of 0-100, where higher scores reflect better health status.

次要结局

  • Changes in cardiac mechanics by echocardiography(Baseline and after 4 weeks of beta blocker discontinuation)
  • Changes in biomarker(Baseline and after 4 weeks of beta blocker discontinuation)
  • 6 minute walk test(Baseline and after 4 weeks of beta blocker discontinuation)

研究者

发起方
UConn Health
申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Pickett

Associate Professor

UConn Health

研究点 (2)

Loading locations...

相似试验